体外释药,in vitro release
1)in vitro release体外释药
1.Preparation andin vitro release of poly(DL-lactide) microspheres containing tinidazole;替硝唑聚乳酸微球的制备及其体外释药性能
2.Study on preparation andin vitro release of 5-fluorouracil loaded polylactide-co-glycolide-co-poly(ethylene glycol) nanoparticles;PEG-PLGA载5-FU纳米缓释微球的制备及体外释药研究
3.Formulation optimization and thein vitro release characteristics of Fuyankang Dispersible Tablets;妇炎康分散片的辅料处方优化及体外释药特性
英文短句/例句
1.Preparation and Drug Releasing Evaluation of Drug Controlled Release in Vitro壳聚糖药物控释体的制备及体外释药评价
2.Preparation and in vitro drug release behavior study of the sustained-release hydrogel based on sulfate chitosanSCS药物缓释凝胶的制备及其体外释药研究
3.Study on Drug Release of Sinomenine External Application Sticking Powder in vitro盐酸青藤碱外敷贴散的体外释药研究
4.Preparation and Evaluation of Delayed Release Microsphere of Dragon"s Blood in Vitro;血竭聚乳酸缓释微球的制备及体外释药研究
5.Preparation and in vitro release of goserelin acetate sustained-release microspheres醋酸戈舍瑞林缓释微球的制备及体外释药研究
6.Preparation of Huperzine A Double-layer Sustained Release Tablets and Their in Vitro Release Characteristics石杉碱甲双层缓释片的研制及体外释药研究
7.Implantable and controlled drug delivery device fabricated by three dimensional printing and its releasing character in vitro三维打印技术制备植入式药物控释装置及体外释药研究
8.Release characters of Mexican Tea Herb self-microemulsifying drug delivery system in vitro土荆芥油自微乳化释药系统的体外释药特性研究
9.Research on Release Rate and Release Characteristics in vitro of the Compound Qufeng Sustained-release Tablets复方祛风缓释片释放度的测定及体外释药特性研究
10.Evaluation of bifendate release from solid lipid nanoparticles in vitro联苯双酯固体脂质纳米粒的体外释药特性评析
11.tudy on in vitro release character and in vivo behavior of harmine gelatin microspheres;去氢骆驼蓬碱明胶微球的体外释药特性与体内药动学研究
12.In vitro release behavior and in vivo pharmacokinetics of ibuprofen inclusion complex in situ gel布洛芬包合物凝胶体外释药行为及体内药代动力学研究
13.Modification of Aspirin by Dextran and in Vitro Release Study;右旋糖酐改性阿司匹林及体外释药研究
14.The Drug Release Investigation of Calcium Sulfate Combined with MTX in Vitro;复合MTX硫酸钙人工骨体外释药特性研究
15.Preparation of Zaltoprofen Gel and Study of Drug Release in Vitro;扎托洛芬凝胶剂的制备及体外释药性研究
16.Study on Preparation and in Vitro Release Experiments of Drugs/montmorillonite Sustained-release Systems;药物/蒙脱土缓释体系的制备和体外释放的研究
17.Controlled-Release Implant System Formulated Using Biodegradable Hemostatic Gauze (Surgicel～(TM));载药纱布缓释植入剂开发及体外释放行为研究
18.Preparation and in vitro release of ketoprofen sustained-release pellets酮洛芬缓释微丸的制备及体外药物释放考察
相关短句/例句
release in vitro体外释药
1.Affecting factor of the diclofenac potassiumrelease in vitro from hydroxypopylmethyl cell ulose tablets;双氯芬酸钾羟丙基甲基纤维素骨架片体外释药的影响因素
2.Preparation of Nanoliposome Coated with Hydroxycamptothecin and Study on Release in vitro;羟基喜树碱包衣纳米脂质体的制备及体外释药研究
3.Preparation of Xionggui nasal sprays and its evaluation inrelease in vitro and absorption in vivo;芎归鼻用喷雾剂的制备及其体外释药与在体吸收特性评析
3)drug release in vitro体外释药
1.Study on preparation anddrug release in vitro of temozolomide-chitosan microspheres;替莫唑胺壳聚糖缓释微球的制备及体外释药特性
2.Influencing factors of ophiopogonin enteric microsphere"drug release in vitro麦冬皂苷肠溶微球体外释药影响因素研究
3.The drug content was examined by Lowry methods, and the drug loading, encapsulation efficiency, anddrug release in vitro were calculated.方法 :用乳化交联法制备胸腺肽明胶微球 ,正交设计法筛选其最佳制备工艺 ,Lowry法测定药物的含量 ,计算微球的载药量、包封率及体外释药量。
4)In vitro drug release体外释药
1.Effects of pH and ionic strength of release media on in vitro drug released from carboxymethyl konjac glucomannan pellets;释放介质pH和离子强度对羧甲基魔芋胶小丸体外释药的影响
2.OBJECTIVE To prepare clindamycin hydrochloride microcapsule by means of intra liquid desiccation and to determine its in vitro drug release.目的采用液中干燥法制备盐酸克林霉素微囊 ,并考察其体外释药特性。
3.And factors influencing in vitro drug release rate of the matrix tablets were studied.以茶碱为模型药物，制备了黄原胶亲水性骨架片，研究了体外释药的影响因素。
5)Drug-release effect in vitro and vivo体内外释药
6)in vitro release property体外释药特性
延伸阅读
抗真菌药和抗立克次氏体药抗真菌药和抗立克次氏体药Chemotherapeutics, Antimycotic and Antirickettsialkans抗真菌药和抗立克次氏体药第9卷 O }}(1)CICH之一C一CHZCI一-~甲~~~~~叫~~一~~~(2)CHaC00H FB了IJ ︸胜、!尸以.纵扮!F(48) OH lCICH:一C一CHZCIN=，、1，1 NH尸丫r，一一三之~、汗尸Na月，DMF F(49)(11) :HzN~3。:。您丫督自气丛立竺竺自护、-跳沪/、‘犷HCOH、屯/卜‘2(51)(52) 。之丫⑧ 坐助OH(‘2，(53)HCI-~~，~~~~~~，..~ 一H20‘HCI(90)侧月FC.\H一\l尸n下.C上z、丫FH C一N =‘ N 1.1七(47)氟康哇口服吸收快而完全，半衰期长(22~32h)体内分布均匀，能很好的透过血脑屏障，并渗透到脑脊液内阳〕。口服100mg后，脑脊液平均浓度为血浆浓度的0.58一0.89倍。70%原药由肾脏排除。大多数病人对氟康哇耐受良好哪〕。常见的副作用为头痛、恶心、疲劳、发热、浮肿、出疹、腹部不适及转氨酶升高。但发生率小于5环，极少数病人出现血小板减少，停药后即恢复。·2.8.烯丙胺类1981年发现蔡替芬(haftifine)(s0)具有较高的广谱抗真菌活性。由于其优良的抗真菌活性，新颖的结构特点，很快引起了人们的重视，通过对其结构改造和抗菌活性的研究，发现了活性高、毒性低的衍生物特比禁芬(terbinafine)(‘oa)和丁禁芬(botenafine)(乐ob)。活性最大，最低抑菌浓度(Mlc)为。.01一0.2哆/ml，对申克氏抱子丝菌和曲霉属真菌次之，Mlc分别为0.8一1.5限/耐和0.8~12.5阳/而。禁替芬的体外抗皮肤真菌活性明显优于咪哇类抗真菌药，而与托蔡醋(发癣退)和灰黄霉素相似。蔡替芬对真菌细胞超微结构有影响，还干扰真菌细胞的脂质代谢，故有杀菌作用。在作用机理上蔡替芬与氮哇类药物一样，都是抑制麦角幽醇的生物合成，但作用部位二者不同，禁替芬是角拨烯的环氧化酶的特异性抑制剂。通过抑制角鳖烯的环氧化，使角盆烯蓄积和麦角幽醉缺乏，使真菌细胞膜的组成和通透性发生改变，导致杀菌作用[5，〕。蔡替芬是一个高效低毒的外用抗真菌药，其疗效与克霉哇、美康哇、益康哇等外用抗真菌药相似。
